Mikov, Momir
Type
Results 1-13 of 13 (Search time: 0.002 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 24-Oct-2019 | Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in Type 1 diabetes development in a murine mode | Armin Mooranian; Nassim Zamani; Giuseppe Luna; Hesham Al-Sallami; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami |
| 2 | 8-Nov-2018 | Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Maja Đanić ; Bojan Stanimirov ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 3 | Feb-2020 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Momir Mikov ; Nebojša Pavlović ; Bojan Stanimirov ; Maja Đanić ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
| 4 | 1-Dec-2018 | Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring | Svetlana Goločorbin-Kon ; Momir Mikov ; Jelena Helen Hogervorst ; Hani Al-Salami; Vladimir Maksimović |
| 5 | 1-Dec-2017 | High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect | Svetlana Goločorbin-Kon ; Jelena Calasan; Boris Milijašević ; Saša Vukmirović ; Mladena Lalić-Popović ; Momir Mikov ; Hani Al-Salami |
| 6 | 1-Apr-2019 | An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques | Armin Mooranian; Nassim Zamani; Ryu Takechi; Giuseppe Luna; Momir Mikov ; Svetlana Goločorbin-Kon ; Magdy Elnashar; Frank Arfuso; Hani Al-Salami |
| 7 | 18-Sep-2018 | Novel nano-encapsulation of probucol in microgels: Scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses | Armin Mooranian; Nassim Zamani; Mikov, Momir ; Goločorbin-Kon, Svetlana ; Stojanović, Goran ; Frank Arfuso; Hani Al-Salami |
| 8 | 12-Nov-2018 | Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses | Armin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Hani Al-Salami |
| 9 | 1-Jan-2018 | Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 10 | 5-Jun-2020 | Pharmacological Effects of Secondary Bile Acid Microparticles in Diabetic Murine Model | Armin Mooranian; Nassim Zamani; Božica Kovačević; Corina Mihaela Ionescu; Giuseppe Luna; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Sanja Kojić ; Hani Al-Salami |
| 11 | 1-Jun-2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
| 12 | 1-Dec-2017 | The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
| 13 | 7-Dec-2019 | A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds | Armin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami |